Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/03/2012US20120108592 Pharmaceutical compositions and methods of use of salicylanilides for treatment of hepatitis viruses
05/03/2012US20120108591 Alkylsulfinyl-substituted thiazolide compounds
05/03/2012US20120108590 Melt-extruded solid dispersions containing an apoptosis-inducing agent
05/03/2012US20120108589 Azabicyclo compound and salt thereof
05/03/2012US20120108588 Novel 3-amido-pyrrolo[3,4-c]pyrazole-5(1h, 4h,6h) carbaldehyde derivatives
05/03/2012US20120108587 Aza- and Diaza-Phthalazine Compounds as P38 Map Kinase Modulators and Methods of Use Thereof
05/03/2012US20120108585 Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators
05/03/2012US20120108584 2h or 3h-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof
05/03/2012US20120108583 Tricyclic Compounds As mPGES-1 Inhibitors
05/03/2012US20120108582 Fused substituted aminopyrrolidine derivative
05/03/2012US20120108581 Fused piperidine compound and pharmaceutical containing same
05/03/2012US20120108579 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
05/03/2012US20120108578 INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
05/03/2012US20120108577 Compounds for the treatment of multi-drug resistant bacterial infections
05/03/2012US20120108576 Thiazole compounds and methods of use
05/03/2012US20120108575 Heterocyclic-substituted piperidine compounds and the uses thereof
05/03/2012US20120108574 Substituted Benzo-Imidazo-Pyrido-Diazepine Compounds
05/03/2012US20120108573 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
05/03/2012US20120108572 Novel benzamides, production thereof, and use thereof as medicaments
05/03/2012US20120108571 Substituted phenoxy n-alkylated thiazolidinediones as estrogen related receptor-alpha modulators
05/03/2012US20120108570 Pharmacological Treatment for Sleep Apnea
05/03/2012US20120108569 8-AZA Tetracycline Compounds
05/03/2012US20120108568 SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS
05/03/2012US20120108567 Thiazolyl-Dihydro-Indazoles
05/03/2012US20120108566 Nicotinamides as jak kinase modulators
05/03/2012US20120108565 Pyrrole carboxylic acid derivatives as antibacterial agents
05/03/2012US20120108564 1,3,4,8-Tetrahydro-2H-Pyrido[1,2-a]Pyradine Derivatives and Use Thereof as HIV Integrase Inhibitor
05/03/2012US20120108563 Methods Of Treating Liposarcoma
05/03/2012US20120108562 Therapeutic compositions and methods
05/03/2012US20120108560 Single phase silicone acrylate formulation
05/03/2012US20120108559 Receptor activator of the rank receptor complex inhibitor
05/03/2012US20120108558 Treatment of Hot Flashes
05/03/2012US20120108557 Fluoroquinolone derivatives for ophthalmic applications
05/03/2012US20120108556 Methods and dosage forms for the treatment of human cancers
05/03/2012US20120108555 Mixtures or Organic Compounds for the Treatment of Airway Diseases
05/03/2012US20120108554 PROCESS FOR PREPARING HIGH PURITY 1alpha-HYDROXY VITAMIN D2
05/03/2012US20120108553 Combination Therapy with Non-Selective COX Inhibitors to Prevent COX-Related Gastric Injuries
05/03/2012US20120108552 Methods of treating acne
05/03/2012US20120108551 Ophthalmic compositions
05/03/2012US20120108550 Use of Derivatives of Polyunsaturated Fatty Acids as Medicaments
05/03/2012US20120108549 Neuroprotective compounds and their use
05/03/2012US20120108548 Molecular tweezers for the treatment of amyloid-related diseases
05/03/2012US20120108547 Inhibitors of tyrosine kinases and uses thereof
05/03/2012US20120108545 Trioxane Monomers and Dimers
05/03/2012US20120108544 Acylated decasaccharides and their use as antithrombotic agents
05/03/2012US20120108543 Sulfated heptasaccharide and its use as an antithrombotic agent
05/03/2012US20120108542 Sulfated octasaccharide and its use as antithrombotic agent
05/03/2012US20120108541 Acylated 1,6-anhydro decasaccharide and its use as an antithrombotic agent
05/03/2012US20120108539 Medicinal Anti Acne Cream And A Process To Make It
05/03/2012US20120108538 Sulfated polysaccharides having antiplasmodial activity and methods and products for identifying antiplasmodial activity
05/03/2012US20120108536 Pharmaceutical composition and method for inhibiting inflammation
05/03/2012US20120108535 2-fluorinated riboses and arabinoses and methods of use and synthesis
05/03/2012US20120108534 Dihydrothienopyrimidines for the treatment of inflammatory Diseases
05/03/2012US20120108533 Novel phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
05/03/2012US20120108532 Pharmaceutical composition for neuroprotective treatment in patients with ictus comprising citicoline and uric acid
05/03/2012US20120108531 Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
05/03/2012US20120108530 Enhanced Neoglycosides Through Neoglycosylation and Methods of Use Thereof
05/03/2012US20120108529 Protease inhibitors
05/03/2012US20120108528 New therapeutic approaches for treating neuroinflammatory conditions
05/03/2012US20120108527 Polymeric topical compositions
05/03/2012US20120108524 Vaccine comprising amb a 1 peptides for use in the treatment of ragweed allergy
05/03/2012US20120108522 Hdac inhibitors and hormone targeted drugs for the treatment of cancer
05/03/2012US20120108517 Agents and methods for denervation
05/03/2012US20120108511 Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
05/03/2012US20120108510 Methods of improving behavioral therapies
05/03/2012US20120108509 Artificial scab for use in an airway
05/03/2012US20120108507 Methods for In Vivo Cell Reprogramming
05/03/2012US20120108505 Thiophenes as glucagon receptor antagonists, compositions, and methods for their use
05/03/2012US20120108503 Methods for treating type i diabetes with leptin and leptin agonists
05/03/2012US20120108501 Protease Inhibitors
05/03/2012US20120108500 Compositions and Methods for Modulating Immunodeficiency Virus Transcription
05/03/2012US20120108497 Compositions for conferring tolerance to viral disease in social insects, and the use thereof
05/03/2012US20120108494 Inhibitors of intracellular urokinase plasminogen activator and methods of use thereof
05/03/2012US20120108493 Polypeptide Fragments Comprising Endonuclease Activity and Their Use
05/03/2012US20120108422 Antifungal 1,2,4-triazolyl Derivatives
05/03/2012US20120107897 Double-stranded oligonucleotides
05/03/2012US20120107775 Methods of Using Botanical-Based Compositions to Treat Microbial Dental Disease
05/03/2012US20120107430 Pre-procedure meal regimen
05/03/2012US20120107429 Composition For The Prevention And Treatment Of Influenza Virus Infection And Composition For Suppressing Neuraminidase Activity Comprising Turmeric Extract
05/03/2012US20120107421 Estrogen receptor alleles that are predictive of increased susceptibility to bone fracture
05/03/2012US20120107417 Effective Antitumor Treatments
05/03/2012US20120107415 Combined disinfection and decontamination agent having increased effectiveness
05/03/2012US20120107414 Pharmaceutical formulations and methods for treating respiratory tract infections
05/03/2012US20120107410 Product for the preparation of dermatological, cosmetic or cosmeceutical compositions intended for skin treatment
05/03/2012US20120107408 Pharmaceutical microparticles
05/03/2012US20120107406 Dry Powder Formulations
05/03/2012US20120107404 Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
05/03/2012US20120107401 Osteoconductive matrices comprising statins and methods of using the same
05/03/2012US20120107400 Sustained release composition of theraputic agent
05/03/2012US20120107399 Process for drying of bibw2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient
05/03/2012US20120107398 Pharmaceutical compositions
05/03/2012US20120107397 Pharmaceutical compositions of valsartan
05/03/2012US20120107393 Pellets for Delivery of Biologically Active Substances
05/03/2012US20120107392 Use of huperzine for disorders
05/03/2012US20120107389 Amphoteric liposomal compositions for cellular delivery of small rna molecules for use in rna interference
05/03/2012US20120107385 Method of treating conditions associated with overactive bladder
05/03/2012US20120107383 Osteoconductive matrices comprising calcium phosphate particles and statins and methods of using the same
05/03/2012US20120107382 Articles incorporating absorbent polymer and ceragenin compound
05/03/2012US20120107381 Powder formulations of potassium-binding active agents
05/03/2012US20120107380 Methods of saponifying xanthophyll esters and isolating xanthophylls
1 ... 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 ... 7860